VIMY Vimy Pharmaceuticals Inc.
Vimy Pharmaceuticals Inc. manufactures complex medicines intended to treat chronic diseases and improve patient access to care. The company manufactures complex medicines and therapeutic products, enabling healthcare providers to treat chronic conditions such as diabetes and obesity while improving the sustainability of universal healthcare systems. Vimy Pharmaceuticals Inc. was incorporated in 2024 and is headquartered in Ontario, Canada.…
Industry Peers
BiotechnologyKey Statistics
About Vimy Pharmaceuticals (CVE: VIMY)
›
Vimy Pharmaceuticals (CVE: VIMY) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 2.700 CAD on 17 November 2026. Its 52-week range is 2.700 CAD to 3.000 CAD, and it trades at the bottom of that range.
Vimy Pharmaceuticals reports an operating margin of 0.0%.